ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.00%
US Tech 100
18,141.60
-0.30%
S&P 500
5,308.13
0.00%
US Dollar vs CAD
1.36636
0.29%
Bitcoin
70,885.39
-0.78%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SAB Biotherapeutics Inc (SABSW)

  7. SAB Biotherapeutics Inc (SABSW) News

SABSW

SAB Biotherapeutics (SABSW)

SAB Biotherapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SABSW
DateTimeSourceHeadlineSymbolCompany
05/21/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SABSWSAB Biotherapeutics Inc
05/20/20244:45PMGlobeNewswire Inc.SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company UpdatesNASDAQ:SABSWSAB Biotherapeutics Inc
05/20/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SABSWSAB Biotherapeutics Inc
05/06/20246:15AMGlobeNewswire Inc.SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of DirectorsNASDAQ:SABSWSAB Biotherapeutics Inc
04/16/20246:15AMGlobeNewswire Inc.SAB Biotherapeutics Provides SAB-142 Trial UpdateNASDAQ:SABSWSAB Biotherapeutics Inc
04/08/20246:15AMGlobeNewswire Inc.SAB Biotherapeutics to Present at INNODIA Annual MeetingNASDAQ:SABSWSAB Biotherapeutics Inc
04/04/20246:15AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SABSWSAB Biotherapeutics Inc
03/29/20246:15AMGlobeNewswire Inc.SAB Biotherapeutics Reports Full Year 2023 Operating and Financial ResultsNASDAQ:SABSWSAB Biotherapeutics Inc
03/25/20249:15AMGlobeNewswire Inc.SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza TreatmentNASDAQ:SABSWSAB Biotherapeutics Inc
02/23/20247:00AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the BIO CEO & Investor ConferenceNASDAQ:SABSWSAB Biotherapeutics Inc
02/08/20247:00AMGlobeNewswire Inc.SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:SABSWSAB Biotherapeutics Inc
02/02/20246:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Executive Leadership ChangeNASDAQ:SABSWSAB Biotherapeutics Inc
01/23/20244:58PMGlobeNewswire Inc.SAB Biotherapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SABSWSAB Biotherapeutics Inc
01/02/20243:30PMGlobeNewswire Inc.SAB Biotherapeutics Announces 1-for-10 Reverse Stock SplitNASDAQ:SABSWSAB Biotherapeutics Inc
11/29/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSWSAB Biotherapeutics Inc
11/20/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Appoints Katie Ellias to the Board of DirectorsNASDAQ:SABSWSAB Biotherapeutics Inc
11/14/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Completion of $67.1 Million Financing to Advance Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSWSAB Biotherapeutics Inc
11/14/20236:15AMGlobeNewswire Inc.SAB Biotherapeutics Announces Q3 2023 Financial Results and Provides Company UpdatesNASDAQ:SABSWSAB Biotherapeutics Inc
11/09/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics to Present at Piper Sandler Healthcare ConferenceNASDAQ:SABSWSAB Biotherapeutics Inc
10/24/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial OfficerNASDAQ:SABSWSAB Biotherapeutics Inc
10/19/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Receives Australian Approval to Commence Phase 1 Clinical Trial of SAB-142, a Potential Disease-Modifying Treatment for Type 1 DiabetesNASDAQ:SABSWSAB Biotherapeutics Inc
10/05/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of DirectorsNASDAQ:SABSWSAB Biotherapeutics Inc
10/02/20236:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 DiabetesNASDAQ:SABSWSAB Biotherapeutics Inc
08/21/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Provides Company Update for Q2 2023 Financial ResultsNASDAQ:SABSWSAB Biotherapeutics Inc
06/21/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Presents Positive IND-Enabling GLP Toxicology Study for SAB-142, a Novel Immunotherapeutic for Type 1 Diabetes at FOCIS 2023NASDAQ:SABSWSAB Biotherapeutics Inc
05/30/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics to Present Novel Human IgG Platform with Positive Data and Breakthrough Therapy and Fast-Track Designations for Influenza Treatment at BIO 2023 International ConventionNASDAQ:SABSWSAB Biotherapeutics Inc
05/19/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio Update: Breakthrough Immunotherapy InnovationsNASDAQ:SABSWSAB Biotherapeutics Inc
05/16/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Provides Company Update for Q1 2023 Financial ResultsNASDAQ:SABSWSAB Biotherapeutics Inc
05/12/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces First Publication of Promising Nonclinical Data for SAB-183 Against Pneumonic Plague in the Journal AntibodiesNASDAQ:SABSWSAB Biotherapeutics Inc
05/09/20237:30AMGlobeNewswire Inc.SAB Biotherapeutics Announces Progress on U.S. FDA’s Phased Review of Company’s Groundbreaking DiversitAb™ PlatformNASDAQ:SABSWSAB Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SABSW

Your Recent History

USOTC
IBGR
Nexus Energy Services (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
TGLO
TheGlobe com (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
MGON
Megola (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
SFLM
SFLMaven (PK)
USOTC
SONGD
Music Licensing (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
EPAZ
Epazz (PK)
USOTC
BLLB
Bell Buckle (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved